Sermo Survey Reveals Widespread Use of Unregulated Peptides Among Patients as Physicians Call for Greater Regulatory Clarity As healthcare providers navigate a rapidly evolving landscape of metabolic and wellness therapies,…
Tempus Unveils Early Results from Multimodal Foundation Models, Demonstrating Potential to Accelerate Precision Oncology and Drug Development Tempus a technology company focused on advancing precision medicine through artificial intelligence, has…
Landmark OPTIMA Trial Demonstrates Veracyte’s Prosigna Test Can Safely Reduce Chemotherapy Use in High-Risk Breast Cancer Patients Veracyte has announced groundbreaking results from the OPTIMA (Optimal Personalised Treatment of Early…
Life Healthcare Advances Strategic Growth Agenda with Capacity Expansion and Improved Operational Performance Life Healthcare Group has reported encouraging progress in the execution of its long-term growth strategy, delivering improved…
RadNet to Host Free Men’s Health Webinar Focused on Early Detection of Heart Disease, Prostate Cancer, and Lung Cancer RadNet,a leading provider of outpatient diagnostic imaging services and radiology technology…
HCA Healthcare to Acquire The College of Health Care Professions in Strategic Move to Strengthen Healthcare Workforce Pipeline HCA Healthcare, Inc one of the largest healthcare providers in the United…
DaVita Sets Ambitious 2030 Community Care Goals After Surpassing Previous ESG Milestones DaVita has unveiled a sweeping new set of 2030 Community Care commitments aimed at transforming kidney care, strengthening…
Ebola Crisis Exposes Failures in Global Health Architecture, Says AIDS Healthcare Foundation As Uganda and the Democratic Republic of the Congo (DRC) grapple with a fast-moving Ebola outbreak, the AIDS…
Phase 3 Ecopipam Data Show Sustained Tic Improvement and Delayed Relapse in Tourette Syndrome Newly published Phase 3 clinical trial results in JAMA Neurology demonstrate that ecopipam, an investigational first-in-class…
AstraZeneca to Showcase Broad Oncology and Rare Disease Pipeline at ASCO 2026 with Late-Breaking Data Across Liver, Breast, Bladder Cancers and Amyloidosis AstraZeneca will present a comprehensive slate of late-breaking…
Datroway® Receives U.S. FDA Approval as First TROP2-Directed Antibody Drug Conjugate for First-Line Treatment of Metastatic Triple-Negative Breast Cancer in Patients Not Eligible for PD-1/PD-L1 Inhibitor Therapy Daiichi Sankyo and…
Accendra Health Launches Comprehensive Debt Exchange and Refinancing Initiative Accendra Health, has initiated a broad debt restructuring transaction designed to strengthen its balance sheet, extend debt maturities, and secure new…
